Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01680744 · ClinicalTrials.gov registry record · NA
The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup
A NA study of Renal Function and Deceased Organ Donor, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 370
- Enrollment target
- 1
- Study location
NCT01680744: Completed NA study of Renal Function and Deceased Organ Donor, sponsored by University of California, San Francisco.
NCT01680744 is a NA study of Renal Function and Deceased Organ Donor that has completed, run by University of California, San Francisco. The registered enrollment target is 370 participants, above the 172-participant average among 3 other Renal Function trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01680744, a NA study of Renal Function and Deceased Organ Donor, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 370 participants
- Enrollment target
- 1
- Study location
Study Summary
To protect kidney function during the transplantation process by inducing mild hypothermia in the deceased organ donor before organs are recovered
Primary Outcome
The primary outcome measures are renal function as determined by creatinine and cystatin c between declaration of neurological death and organ recovery in each of the two treatment groups. Delta creatinine and terminal creatinine are important predictors of graft quality and function, as demonstrated in the present data (HRSA study and Region 5 DMG/DGF study), and will be compared between the control and treatment group.
Conditions Studied
Interventions
- OTHER Hypothermia
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT01680744 record still lists
NCT01680744 is an interventional study that assigns participants to a tested intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap, above the 172-participant average among 3 other Renal Function trials with a reported enrollment target (115% higher).
The record links to 3 conditions, with Renal Function appearing as the primary indexed condition, and to 1 intervention - of which Hypothermia is the first listed.
NCT01680744 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01680744 about?
NCT01680744 is a clinical study titled "The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup". To protect kidney function during the transplantation process by inducing mild hypothermia in the deceased organ donor before organs are recovered
What is the current status of trial NCT01680744?
This trial is currently completed. It is a NA study. The enrollment target is 370 participants. The study started on 2012-05. Estimated completion is 2014-11.
What conditions does trial NCT01680744 study?
This clinical trial studies the following conditions: Renal Function, Deceased Organ Donor, Mild Hypothermia.
What interventions are being tested in trial NCT01680744?
The interventions under investigation include: Hypothermia (OTHER).
Who is sponsoring clinical trial NCT01680744?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01680744 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Function
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RECRUITING · NA
-
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
RECRUITING
-
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia